The World Health Organization reports that more than 3.4 million women die from heart disease every year.
+ More heart disease facts & figures
Philips understands that heart disease can manifest differently in women than in men, in smaller vessels with less obstruction and more subtle symptoms.
We are proud to bring to market products that integrate our new DXL ECG Algorithm, which incorporates recent gender-specific research findings. Using these as well as age- and lead-specific STEMI criteria, the DXL Algorithm responds to the latest AHA/ACCF/HRS recommendations for acute ischemia and infarcts, as published in March 2009.
As a leader in Cardiology we offer a complete portfolio of solutions for women, but recognize there is more to be done. We continue to work closely with leading healthcare organizations, patients and clinicians to better understand heart disease in women and provide solutions to improve early detection.
Products that integrate our new DXL ECG Algorithm: